Tonix Pharmaceuticals Holding Corp. (TNXP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Tonix Pharmaceuticals Hol...

NASDAQ: TNXP · Real-Time Price · USD
24.00
-0.72 (-2.91%)
At close: Oct 03, 2025, 3:59 PM
24.10
0.42%
After-hours: Oct 03, 2025, 07:58 PM EDT

Tonix Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
98.78M 24.95M 120.23M 178.66M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
904K n/a 241K 240K
Other Long-Term Assets
47K 1.13M 143K 259K
Receivables
7.9M 4.59M n/a 7.73M
Inventory
8.41M 14.15M -8.04M -7.73M
Other Current Assets
3.91M 2.43M 1.23M 1.18M
Total Current Assets
119M 47.77M 130.78M 189.05M
Property-Plant & Equipment
42.82M 94.85M 94.53M 51.47M
Goodwill & Intangibles
120K 10.71M 120K 120K
Total Long-Term Assets
43.89M 106.69M 94.91M 51.85M
Total Assets
162.89M 154.46M 225.69M 240.9M
Account Payables
4.55M 3.78M 8.07M 13.28M
Deferred Revenue
n/a 2.98M 3.27M 2.83M
Short-Term Debt
3.09M 2.35M n/a n/a
Other Current Liabilities
6.04M 5.14M 2.76M 2.25M
Total Current Liabilities
18.31M 18.88M 18.18M 21.72M
Long-Term Debt
4.67M 6.56M n/a n/a
Other Long-Term Liabilities
n/a 22.86M n/a n/a
Total Long-Term Liabilities
5.03M 30.05M 328K 467K
Total Liabilities
23.33M 48.93M 18.51M 22.18M
Total Debt
8.12M 9.81M 760K 956K
Book Value
139.56M 105.53M 207.18M 218.72M
Book Value Per Share
61.66 57.61 67.51 31.02
Common Stock
4K 59K 76K 496K
Retained Earnings
-730.69M -600.66M -470.04M -359.82M
Comprehensive Income
-255K -232K -167K -92K
Shareholders Equity
139.56M 105.53M 207.18M 218.72M
Total Investments
904K 900K 241K 240K